Research Output per year
Fingerprint Dive into the research topics where Sven Stegemann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 5 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
Age-related medicine
Wahlich, J., Orlu, M., Mair, A., Stegemann, S. & Van Riet-Nales, D., 1 Apr 2019, In : Pharmaceutics . 11, 4, 172.Research output: Contribution to journal › Article › Research › peer-review
Open Access
An evaluation of the gliding performance of solid oral dosage form film coatings using an artificial mucous layer
Drumond, N. & Stegemann, S., 1 May 2019, In : Colloids and Surfaces B: Biointerfaces. 177, p. 235-241 7 p.Research output: Contribution to journal › Article › Research › peer-review
EMA : Die Expertise der Apotheker ist gefragt.
Stegemann, S., 1 Jan 2018, In : Österreichische Apotheker-Zeitung. 72, 1, p. 60-62 3 p.Research output: Contribution to journal › Article › Research
Ensuring parenteral biologics’ quality and safety
Stegemann, S., 1 Jul 2018, In : AAPS Newsmagazine. 7, p. 12-17 5 p.Research output: Contribution to journal › Article › Research › peer-review
Formulation and methodological assessment of patient centric technologies for solid oral dosage forms (SODF)
Drumond, N. & Stegemann, S., 22 Mar 2018.Research output: Contribution to conference › Poster › Research › peer-review
Open Access
File
Activities
From ‘me-too’ to ‘added value me too’ to ‘enhanced therapeutic’ (“supergeneric”): A way to create competitive advantages in the generic business
Sven Stegemann (Speaker)22 Apr 2016
Activity: Talk or presentation › Invited talk › Science to science
From patient research to patient centric product design: Focusing on the geriatric and pediatric population
Sven Stegemann (Speaker)27 May 2016
Activity: Talk or presentation › Invited talk › Science to science
Opportunities for generic developers
Sven Stegemann (Speaker)27 Jan 2016
Activity: Talk or presentation › Invited talk › Science to science
Formulatión de medicamentos para uso pediatrico (Patient Centric solutions: The Sprinkle capsule in association with microparticulate formulations.)
Sven Stegemann (Speaker)18 Feb 2016
Activity: Talk or presentation › Invited talk › Science to science
Hard gelatin capsule formulation development based on QbD
Sven Stegemann (Speaker)27 Jan 2016
Activity: Talk or presentation › Invited talk › Science to science
Projects
- 2 Finished
SV-PCPL - SV-PatientcentricProductLab - Patient Centric Drug Product Design & Manufacturing
Stegemann, S. & Drumond Freitas, N. D.
1/01/16 → 1/07/16
Project: Research project